ConoGenetix conogenetix.de


Public lists: Pharma Startups (4733)

ConoGenetix focuses on the development of new peptide therapeutics for the treatment of autoimmune diseases.

ConoGenetix focuses on the development of new peptide therapeutics for the treatment of autoimmune diseases.

Company (Alive / Active)

Phone: +49 (0)89 547269-50

Fax:

Am Klopferspitz 19

Martinsried, 82152
Germany

Latest News

See more competitors data Competitors
Total Funding Date of Last Funding
ConoGenetix $2M May 9, 2012

Web Traffic

Rank

Show (-10)

Engagement (PVPU)

Show (+1%)

Domain Authority Score
Show
Page Views Per Million (PVPM)
Show
Reach Per Million
Show

SEO Statistics

Domain Authority Score Show
Page Authority Score Show
No. External Links Show
No. Links Show

Web Traffic Statistics - Growth

Per Week Per Month Per 6 Months Per Year
Rank Login to see details
Page Views Per Million Login to see details
Page Views Per User Login to see details
Reach Per Million Login to see details

Related ConoGenetix Jobs

jobs by Indeed job
						search

Investors

Investor Investor Type Location Participating Rounds
See all 1 investors
There is no Board of Directors data available for this company. Please select another tab.
There is no Competitors data available for this company. Please select another tab.

Patents

Title Application Date Patent Date Status
(Patent / Application)
Kv1.3 potassium channel antagonists May 07, 2015 Application